| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4879071
Max Phase: Preclinical
Molecular Formula: C19H21N3O6S
Molecular Weight: 419.46
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCOC(=O)NC(=O)c1ccsc1NC(=O)c1coc(C(=O)N2CCCCC2)c1
Standard InChI: InChI=1S/C19H21N3O6S/c1-2-27-19(26)21-16(24)13-6-9-29-17(13)20-15(23)12-10-14(28-11-12)18(25)22-7-4-3-5-8-22/h6,9-11H,2-5,7-8H2,1H3,(H,20,23)(H,21,24,26)
Standard InChI Key: IPERIVLXDUIAKK-UHFFFAOYSA-N
Associated Targets(non-human)
Mycobacterium tuberculosis 203094 Activities
Vero 26788 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase 247 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 419.46 | Molecular Weight (Monoisotopic): 419.1151 | AlogP: 3.11 | #Rotatable Bonds: 5 |
| Polar Surface Area: 117.95 | Molecular Species: ACID | HBA: 7 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 6.08 | CX Basic pKa: | CX LogP: 2.69 | CX LogD: 1.44 |
| Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.77 | Np Likeness Score: -1.71 |
References
| 1. Wang P, Batt SM, Wang B, Fu L, Qin R, Lu Y, Li G, Besra GS, Huang H.. (2021) Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities., 64 (9.0): [PMID:33852302] [10.1021/acs.jmedchem.1c00263] |
Source
Source(1):